{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T22:40:34Z","timestamp":1684190434136},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s12098-007-0206-8","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T10:30:34Z","timestamp":1200652234000},"page":"1105-1108","source":"Crossref","is-referenced-by-count":1,"title":["Redefining the management of pediatric tonsillopharyngitis with Cefprozil"],"prefix":"10.1007","volume":"74","author":[{"given":"Nameet","family":"Jerath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,19]]},"reference":[{"key":"206_CR1","first-page":"83","volume":"61","author":"Z. Vranjes","year":"2007","unstructured":"Vranjes Z, Kati\u00e6 V, Vinter-Repalust N, Jurkovi\u00e6 L, Tiljak H, Cerovecki-Neki\u00e6 V et al. Acute infections of the upper respiratory tract-factors that contribute to diagnosis and antibiotic prescription decisions. Acta Med Croatica 2007; 61: 83\u201390.","journal-title":"Acta Med Croatica"},{"key":"206_CR2","unstructured":"Esposito S, Blasi F, Droghetti R, Bosis S, Cavagna R, Capone P et al. Emerging Role of Atypical Bacteria in Children with Acute Pharyngitis. Intersci Conf Antimicrob Agents Chemother 2001; 41: Abstract no. G-536."},{"key":"206_CR3","unstructured":"www.entnet.org\/KidsENT\/tonsillitis.cfm."},{"key":"206_CR4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/00006454-199211120-00010","volume":"11","author":"J.W. Bass","year":"1992","unstructured":"Bass JW. Antibiotic management of group A streptococcal pharyngotonsillitis. Pediatr Infect Dis J 1992; 11: 1043\u20131046.","journal-title":"Pediatr Infect Dis J"},{"key":"206_CR5","first-page":"1557","volume":"63","author":"S.H. Cynthia","year":"2001","unstructured":"Cynthia SH, Williamson H. Management of Group A Beta-Hemolytic Streptococcal Pharyngitis. Am Fam Physician 2001; 63: 1557\u20131565.","journal-title":"Am Fam Physician"},{"key":"206_CR6","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1001\/jama.287.23.3096","volume":"287","author":"L.F. McCraig","year":"2002","unstructured":"McCraig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287: 3096\u20133102.","journal-title":"JAMA"},{"key":"206_CR7","first-page":"1567","volume":"42","author":"M.E. Pichichero","year":"1990","unstructured":"Pichichero ME. Controversies in the treatment of streptococcal pharyngitis. Am Fam Physician 1990; 42: 1567\u20131576.","journal-title":"Am Fam Physician"},{"key":"206_CR8","first-page":"782","volume":"22","author":"M.E. Pichichero","year":"1996","unstructured":"Pichichero ME. Streptococcal pharyngitis: is penicillin still the right choice? Compr Ther 1996; 22: 782\u2013787.","journal-title":"Compr Ther"},{"key":"206_CR9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.113.4.866","volume":"113","author":"R.C. Janet","year":"2004","unstructured":"Janet RC, Pichichero ME. Meta-analysis of Cephalosporin Versus Penicillin Treatment of Group A Streptococcal Tonsillopharyngitis in Children. Pediatrics 2004; 113: 866\u2013882.","journal-title":"Pediatrics"},{"key":"206_CR10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1542\/peds.96.4.758","volume":"96","author":"A. Dajani","year":"1995","unstructured":"Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute Streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96: 758\u2013764.","journal-title":"Pediatrics"},{"key":"206_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006454-199104000-00002","volume":"10","author":"M.E. Pichichero","year":"1991","unstructured":"Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10: 275\u2013281.","journal-title":"Pediatr Infect Dis J"},{"key":"206_CR12","first-page":"740","volume":"14","author":"R.G. Deeter","year":"1992","unstructured":"Deeter RG, Kalman DL, Rogan MP, Chow SC. Therapy for pharyngitis and tonsillitis caused by group A beta-hemolytic Streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V. Clin Ther 1992; 14: 740\u2013754.","journal-title":"Clin Ther"},{"key":"206_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02723613","volume":"70","author":"S. Bhargava","year":"2003","unstructured":"Bhargava S, Lodha R, Kabra SK. Cefprozil: a review. Indian J Pediatr 2003; 70: 395\u2013400.","journal-title":"Indian J Pediatr"},{"key":"206_CR14","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1128\/AAC.37.8.1620","volume":"37","author":"D. Milatovic","year":"1993","unstructured":"Milatovic D, Adam D, Hamilton H, Materman E. Cefprozil versus penicillin V in the treatment of streptococcal tonsillopharyngitis. Antimicrobial Agents Chemotherapy 1993; 37: 1620\u20131623.","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"206_CR15","unstructured":"www.fda.gov\/medwatch\/safety\/1997\/apr97.htm"},{"key":"206_CR16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/BF02111350","volume":"13","author":"R. Wise","year":"1994","unstructured":"Wise R. Comparative microbiological activity and pharmacokinetics of cefprozil. Eur J Clin Microbiol Infect Dis 1994; 13: 839\u2013845.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"206_CR17","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1093\/clinids\/14.Supplement_2.S184","volume":"14","author":"S.L. Barriere","year":"1992","unstructured":"Barriere SL. Pharmacology and pharmacokinetics of cefprozil. Clin Infect Dis 1992; 14: S184\u2013S188; discussion S195-S1966.","journal-title":"Clin Infect Dis"},{"key":"206_CR18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/AAC.37.5.1180","volume":"37","author":"W.C. Shyu","year":"1993","unstructured":"Shyu WC, Reilly J, Campbell DA, Wilber RB, Barbhaiya RH. Penetration of Cefprozil into Tonsillar and Adenoidal Tissues. Antimicrob Agents Chemother 1993; 37: 1180\u20131183.","journal-title":"Antimicrob Agents Chemother"},{"key":"206_CR19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/j.1552-4604.1992.tb03885.x","volume":"32","author":"W.C. Shyu","year":"1992","unstructured":"Shyu WC, Shah VR, Campbell DA, Wilber RB, Pittman KA, Barbhaiya RH. Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans. J Clin Pharmacol 1992; 32: 798\u2013803.","journal-title":"J Clin Pharmacol"},{"key":"206_CR20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.35.6.1127","volume":"35","author":"J.C. Christenson","year":"1991","unstructured":"Christenson JC, Swenson E, Gooch WM III, Herrod JN. Comparative Efficacy and Safety of Cefprozil and Cefaclor in the Treatment of Acute Group A Beta-Hemolytic Streptococcal Pharyngitis. Antimicrobial Agents And Chemotherapy 1991; 35: 1127\u20131130.","journal-title":"Antimicrobial Agents And Chemotherapy"},{"key":"206_CR21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF02724119","volume":"71","author":"N. Gupta","year":"2004","unstructured":"Gupta N, Mukherjee A, Moharana AK. Pediatric tonsillopharyngitis-An evaluation of Cefprozil in Indian Patients. Indian J Paediatr 2004; 71: 601\u2013605.","journal-title":"Indian J Paediatr"},{"key":"206_CR22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/AAC.31.3.480","volume":"31","author":"N.X. Chin","year":"1987","unstructured":"Chin NX, Neu HC. Comparative antibacterial activity of a new oral cephalosporin, BMY-28100. Antimicrob. Agents Chemother 1987; 31: 480\u2013483.","journal-title":"Agents Chemother"},{"key":"206_CR23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.31.4.653","volume":"31","author":"G.M. Eliopoulos","year":"1987","unstructured":"Eliopoulos GM, Reizner E, Wennerstein C, Moellering RC Jr. In vitro activity of BMY-28100, a new oral cephalosporin. Antimicrob. Agents Chemother 1987; 31: 653\u2013656.","journal-title":"Agents Chemother"},{"key":"206_CR24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJM196412312712705","volume":"271","author":"R. Knudsin","year":"1964","unstructured":"Knudsin R, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. N Engl J Med 1964; 271: 1395\u20131397.","journal-title":"N Engl J Med"},{"key":"206_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijantimicag.2003.05.015","volume":"23","author":"D.A. Kafetzis","year":"2004","unstructured":"Kafetzis DA, Liapi G, Tsolia M, Aoudi H, Mathioudakis J, Paraskakis I, Bairamis T. Failure to eradicate Group A betahaemolytic Streptococci (GABHS) from the upper respiratory tract after antibiotic treatment. Int J Antimicrob Agents 2004; 23: 67\u201371.","journal-title":"Int J Antimicrob Agents"},{"key":"206_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02725655","volume":"71","author":"A. Shet","year":"2004","unstructured":"Shet A, Kaplan E. Addressing the burden of group A streptococcal disease in India. Indian J Pediatr 2004; 71: 41\u201348.","journal-title":"Indian J Pediatr"},{"key":"206_CR27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00006454-199809000-00012","volume":"17","author":"M.E. Pichichero","year":"1998","unstructured":"Pichichero ME, Green JL, Francis AB et al. Recurrent group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 1998; 17: 809\u2013815.","journal-title":"Pediatr Infect Dis J"},{"key":"206_CR28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/28.4.581","volume":"28","author":"J.C. Christenson","year":"1991","unstructured":"Christenson JC, Gooch WM, Herrod JN, Swenson E. Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections. J Antimicrob Chemother 1991; 28: 581\u2013586.","journal-title":"J Antimicrob Chemother"},{"key":"206_CR29","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/00006454-199808001-00007","volume":"17","author":"G. Aronovitz","year":"1998","unstructured":"Aronovitz G. Treatment of upper and lower respiratory tract infections: clinical trials with Cefprozil. Pediatr Infect Dis J 1998; 17: S83\u2013S88.","journal-title":"Pediatr Infect Dis J"},{"key":"206_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3928\/0090-4481-19930301-07","volume":"22","author":"H.R. Stutman","year":"1993","unstructured":"Stutman HR. Cefprozil. Pediatr Ann 1993; 22: 167\u2013168, 171\u2013176.","journal-title":"Pediatr Ann"},{"key":"206_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0149-2918(02)85125-6","volume":"24","author":"D.R. Guay","year":"2002","unstructured":"Guay DR. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin. Clin Ther 2002; 24: 473\u2013489.","journal-title":"Clin Ther"},{"key":"206_CR32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00007611-199503000-00018","volume":"88","author":"R.B. Gainer 2nd","year":"1995","unstructured":"Gainer RB 2nd. Cefprozil, a new cephalosporin: its use in various clinical trials. South Med J 1995; 88: 338\u2013346.","journal-title":"South Med J"},{"key":"206_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-199345020-00008","volume":"45","author":"L.R. Wiseman","year":"1993","unstructured":"Wiseman LR, Benfield P. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs 1993; 45: 295\u2013317.","journal-title":"Drugs"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-007-0206-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-007-0206-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-007-0206-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T22:21:19Z","timestamp":1684189279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-007-0206-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s12098-007-0206-8","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}